M. Hindsø et al., “Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes”, EJCRIM, vol. 8, no. 3, Mar. 2021, doi: 10.12890/2021_002352.